Cheyne Capital Management (UK)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Cheyne Capital Management (UK)’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-187,086	Closed	-$4.27M	–	81
2015 Q2	$4.27M	Sell	187,086 -156,366	-46%	-$3.11M	1.38%	11
2015 Q1	$5.22M	Buy	343,452 +78,944	+30%	+$1.03M	1.26%	16
2014 Q4	$3.19M	Buy	264,508 +92,155	+53%	+$1.05M	0.84%	22
2014 Q3	$1.96M	Buy	+172,353	New	+$1.97M	0.7%	19

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Cheyne Capital Management (UK)'s MNTA Position: Q3 2015 in Review

Cheyne Capital Management (UK) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2015, closing a stake of 187,086 shares — an estimated $4.27M sold.

Cheyne Capital Management (UK) first reported a position in MNTA in Q3 2014 and held it in 4 quarters. The position peaked at $5.22M in Q1 2015. 156 funds tracked by Wall St. Rank hold MNTA as of Q3 2015.

Cheyne Capital Management (UK) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Cheyne Capital Management (UK) sold 187,086 Momenta Pharmaceuticals, Inc. shares in Q3 2015, an estimated $4.27M.
Cheyne Capital Management (UK) first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
Cheyne Capital Management (UK)'s Momenta Pharmaceuticals, Inc. position peaked at $5.22M in Q1 2015.
156 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2015.

Based on Cheyne Capital Management (UK)'s 13F filing for Q3 2015, filed 19 Oct 2015.